Effect of cinnamaldehyde derivatives on survival and growth of glioblastoma cells

Takeaway

  • Combination of 2’-hydroxycinnamaldehyde (HCA) or its derivative 2’-benzoyloxycinnamaldehyde (BCA) with temozolomide (TMZ) decreased cell viability, stemness, and invasiveness in glioblastoma (GBM) tumorspheres (TS) in vitro and slowed tumor growth in vivo in a mouse xenograft model.

  • This combination could be a new therapeutic option for slowing progression of GBM.

Why this matters ?

  • GBM is the most common primary brain tumor, highly aggressive, and associated with poor prognosis; it is frequently resistant to conventional therapies, so novel treatment strategies are desperately needed.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.